文献速递泌尿生殖与妇科肿瘤放疗放疗物理与技术

前列腺癌根治性SBRT后性功能障碍的剂量学分析:MIRAGE试验二次分析

Dosimetric analysis of post-radiotherapy sexual dysfunction in patients receiving definitive stereotactic body radiotherapy (SBRT) for prostate cancer: a secondary analysis of MIRAGE.
PubMed 文献 · Radiother Oncol · 2026-07-11

结果显示MRI组NVB和IPA的V36Gy与V20Gy显著更低,右侧NVB最大剂量与性功能下降可能性增加相关(p<0.05)。结论提示积极缩小边界的非有意保护效应可能减少NVB和IPA接受中低剂量照射的体积,从而解释MRgSBRT后性功能下降率降低。

要点

  • MRI组NVB和IPA的V36Gy与V20Gy显著低于CT组。
  • 右侧NVB最大剂量与性功能下降可能性增加相关(p<0.05)。
  • 积极缩小边界可能通过非有意保护效应减少中低剂量照射体积。

核心结论

  • 积极缩小边界的非有意保护效应可能减少NVB和IPA接受中低剂量照射的体积,从而解释MRgSBRT后性功能下降率降低。

主要发现

  • 基线SHIM评分在MRI组略高,但EPIC26-SF相同。
  • 研究臂间治疗特征(如水凝胶间隔物、GTV boost或ADT使用)无显著差异。
  • MRI组NVB和IPA的V36Gy与V20Gy显著更低。
  • 右侧NVB最大剂量与性功能下降可能性增加相关(p<0.05)。

关键数值与推荐

  • MRI组NVB和IPA的V36Gy与V20Gy显著低于CT组。
  • 右侧NVB最大剂量与性功能下降可能性增加相关(p<0.05)。

临床怎么用

  • 在前列腺癌SBRT计划中关注NVB和IPA的中低剂量体积(如V36Gy、V20Gy),可能有助于减少性功能下降。

局限性

  • 该分析为探索性二次分析,结论有限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: The etiology of the improved long-term sexual function seen following MRI-guided stereotactic body radiotherapy (SBRT) with aggressive margin reduction for prostate cancer remains unknown. METHODS AND MATERIALS: To investigate potential explanatory mechanisms for this finding, we conducted a secondary analysis of data collected for the prospective, randomized phase III MIRAGE trial. Dosimetric data for the structures hypothesized to drive sexual function decline (neurovascular bundles (NVB) and internal pudendal arteries (IPA)) were retrospectively collected and analyzed for correlations with treatment arm or clinically significant sexual function decline as measured by patient reported outcome (PRO) surveys focused on sexual function, namely the EPIC26-SF and SHIM scores. RESULTS: One-hundred-and-seventeen participants from the MIRAGE trial (CT-arm: 58, MRI-arm: 59), corresponding to 75 % of the overall cohort, had complete sexual function PRO survey responses at 24 months. Baseline SHIM score was slightly higher in the MRI arm although EPIC26-SF was the same. No significant differences were noted in treatment characteristics (such as hydrogel spacer, GTV boost, or ADT use) between the study arms. Patients in the MRI group were noted to have significantly lower V36Gy and V20Gy for the NVBs and IPAs. Maximum dose to the right NVB was associated with increased likelihood of sexual function decline (p < 0.05). CONCLUSIONS: Although this analysis is limited in its exploratory nature, the data suggest that the unintentional sparing effect of aggressive margin reduction may be associated with a reduction in volume of the NVBs and IPAs receiving intermediate- or low-dose radiation. This, in turn, could explain the reduced rates of sexual function decline experienced by patients receiving MRgSBRT.

来源:Radiother Oncol,查看原文。版权归原作者所有。

引用

  1. Massachi J, Jiang T, Neilsen BK, et al. Dosimetric analysis of post-radiotherapy sexual dysfunction in patients receiving definitive stereotactic body radiotherapy (SBRT) for prostate cancer: a secondary analysis of MIRAGE. Radiother Oncol. 2026. PMID: 42435817. doi:10.1016/j.radonc.2026.111683

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。